Literature DB >> 19211826

Long-term marginal zinc supply is not detrimental to the skeleton of aged female rats.

Reinhold G Erben1, Katja Lausmann, Paul Roschger, Christiane Schüler, Monika Skalicky, Klaus Klaushofer, Wilhelm Windisch.   

Abstract

In this experiment, we investigated the long-term effects of a marginal zinc (Zn) supply on bone metabolism in aged rats. Nine-mo-old female Fischer-344 rats were divided into 8 weight-matched groups of 8 rats each. All rats were adapted for 1 mo to restrictive feeding (7.5 g/d) of a purified diet containing 8 g/kg sodium phytate and 64 mg/kg Zn. Control rats were pair-fed throughout the experiment. During the 1-mo depletion phase, controls received the Zn-replete diet with 64 mg/kg Zn, whereas Zn-deficient rats were fed the same diet with 2.2 mg/kg Zn. The depletion phase was followed by a 3-mo marginal phase in which the rats fed the diet with 2.2 mg/kg Zn received an additional daily Zn supplement of 75 microg Zn/rat by gavage. In the following 2-mo repletion phase, a marginal group was switched to the Zn-replete diet, while the other groups were maintained on marginal Zn supply or on the Zn-replete diet. Zn depletion and marginal Zn reduced serum and bone Zn and serum alkaline phosphatase activity. Zn repletion normalized serum Zn. However, apart from subtle changes in bone mineralization density distribution, Zn deficiency was not associated with detrimental effects on bone mineral density, turnover, architecture, or biomechanics relative to control rats at any time point. Our data suggest that Zn does not play an essential role in bone metabolism in aged rats and cast doubt on the hypthosis that Zn deficiency is a risk factor for osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211826     DOI: 10.3945/jn.108.099077

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  2 in total

1.  Implications of compromised zinc status on bone loss associated with chronic inflammation in C57BL/6 mice.

Authors:  Pitipa Chongwatpol; Elizabeth Rendina-Ruedy; Barbara J Stoecker; Stephen L Clarke; Edralin A Lucas; Brenda J Smith
Journal:  J Inflamm Res       Date:  2015-07-13

2.  Impact of long-term exposure to the tyrosine kinase inhibitor imatinib on the skeleton of growing rats.

Authors:  Josephine T Tauer; Lorenz C Hofbauer; Roland Jung; Sebastian Gerdes; Ingmar Glauche; Reinhold G Erben; Meinolf Suttorp
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.